Malta vs Viet Nam: Life science patents granted, by filing office
Malta
0 patents
in 2023
Viet Nam
0 patents
in 2023
Malta rank
48th
Viet Nam rank
48th
Life science patents granted, by filing office over time
- Malta
- Viet Nam
How they compare
Malta currently reports 0 patents against 0 patents in Viet Nam, a difference of 0 patents.
The two have swapped places 5 times across 44 shared years of data; in 1980 it was Malta ahead.
Malta ranks 48th and Viet Nam ranks 48th of 70 countries.
Malta has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Malta | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.9 patents | 0.3 patents | 2.6 patents | Malta |
| 1990s | 0.8 patents | 0 patents | 0.8 patents | Malta |
| 2000s | 0 patents | 0 patents | 0 patents | — |
| 2010s | 0 patents | 0 patents | 0 patents | — |
| 2020s | 0 patents | 0 patents | 0 patents | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by filing office, Malta or Viet Nam?
- Malta, at 0 patents against 0 patents in Viet Nam as of 2023.
- What is the difference in life science patents granted, by filing office between Malta and Viet Nam?
- 0 patents, with Malta ahead.
- How many years of comparable data are there for Malta and Viet Nam?
- 44 years are reported by both, from 1980 to 2023.
- How do Malta and Viet Nam rank globally for life science patents granted, by filing office?
- Malta ranks 48th and Viet Nam ranks 48th of 70 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by filing office. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patents granted within the fields of medical technology, biotechnology, and pharmaceuticals by filing office. These patents cover a wide range of innovations, such as medical devices, diagnostic methods, genetic engineering techniques, biotechnological processes and new drugs.